Efficacy and tolerability of first-line chemotherapy in elderly patients ( age >= 70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Aldemir, M. N.Turkeli, M.Hacioglu, B.Sakin, A.Yaman, E.Coban, E.Koca, D.Karaca, M.Simsek, M.Bahceci, A.Sen, E.Eren, T.Aliustaoglu, B. O.Sakalar, T.Kalkan, N. O.Aktas, G.Bilici, M.Turhal, S.Benekli, M.Tekin, S. B.2020-10-222020-10-222016-10-01Aldemir M. N. , Turkeli M., Hacioglu B., Sakin A., Yaman E., Coban E., Koca D., Karaca M., Simsek M., Bahceci A., et al., -Efficacy and tolerability of first-line chemotherapy in elderly patients ( age >= 70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)-, 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27http://hdl.handle.net/20.500.12645/23557https://www.sciencedirect.com/science/article/pii/S0923753419442798?via%3DihubOncologyEfficacy and tolerability of first-line chemotherapy in elderly patients ( age >= 70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Conference PaperWOS:00039391250065610.1093/annonc/mdw371.42